• Fosun Group Introduction
  • Fosun Group

Introduction To Fosun Group

Fosun Group

Introduction To Fosun Group

Fosun Group
Fosun has become a global innovation-driven consumer group
Fosun was founded in 1992. After more than 30 years of development, Fosun has become a global innovation-driven consumer group.
Adhering to the mission of creating happier lives for families worldwide, Fosun is committed to creating a global happiness ecosystem fulfilling the needs of families worldwide in Health, Happiness and Wealth.
In 2007, Fosun International Limited was listed on the main board of the Hong Kong Stock Exchange (stock code: 00656.HK). As of 31 December 2025, Fosun International’s total assets amounted to RMB716.2 billion, and its latest MSCI ESG rating is AAA.
  • 173.43
    2025 Total Revenue (B RMB)
  • 7162
    Total Assets as of Dec 31, 2025
    (B RMB)
  • AAA
    MSCI ESG Rating
  • Mission
    Making families worldwide happier
    MISSION
  • Vision
    Rooted in China, serving global families, building a happy ecosystem of health, joy and prosperity
    VISION
  • Values
    Self-cultivation, family, career, and the world
    VALUES
Milestones
Rooted in China, Fosun has been developing globally and has long adhered to the two core growth drivers of “innovation” and “globalization”. Fosun is one of the few Chinese companies that is equipped with global operation and investment capabilities, and has accumulated profound technology and innovation capabilities.
1992 1994 1998 2002 2011 2010 2007 2003 2012 2013 2014 2015 2019 2018 2017 2016 2020 2021 2022 2023 2025 2024 Founded with RMB 38,000 Fosun Pharma, Forte Fosun Pharma A-share IPO Yuyuan Inc. BFC Bund Finance Center Club Med, Henlius Hainan Mining; Fosun Int'l HK IPO (00656.HK) Sinopharm Group Fosun Prudential, Peak Re, StarCove Atlantis Sanya; Chancheng Hospital; Sisram Medical Fidelidade, Luz Saúde, Roc Oil Silver Cross; full Club Med acquisition FFT; Henlius HK IPO Lanvin, Wolford, Baihe, Songhelou; Fosun Tourism IPO Fosun United Health, Intuitive-Fosun, Kairos Gland Pharma, HAFS, Wolves, BabyTree, AHAVA DJULA, WEI, Shede Spirits Sergio Rossi, Wansheng Co. Lanvin Group NYSE IPO; Yelanggu Winery Yuyuan Lantern Festival abroad YP05002 & small-molecule drugs licensed overseas Henlius HANQUYOU, HANSIZHUANG, HANLIKANG go global; Super-Mediterranean
1992
Founded with RMB 38,000
1994
Founded with RMB 38,000
1998
Fosun Pharma A-share IPO
2002
Yuyuan Inc.
2003
Sinopharm Group
2007
Hainan Mining; Fosun International HKEX IPO (00656.HK)
2010
Club Med, Henlius
2011
BFC Bund Financial Center
2012
Peak Re, Star Castle
2013
Atlantis Sanya, Foshan Fosun Chancheng Hospital, Sisram Medical
2014
Fidelidade, Luz Saúde, Roc Oil
2015
Silver Cross; Full acquisition of Club Med
2016
Gland Pharma, HAFS, Wolverhampton Wanderers, BabyTree, AHAVA
2017
Fosun United Health, Intuitive Fosun, Fosun Kairos
2018
Wolford,
Baihe Jiayuan, Song He Lou; Fosun Tourism HKEX IPO
2019
FFT; Henlius HKEX IPO
2020
DJULA, WEI, Shede Spirits
2021
Sergio Rossi, Wansheng
2022
Lanvin Group NYSE IPO; Yelanggu Winery
2023
Yuyuan Lantern Festival goes global
2024
Henlius HAN QU YOU, HAN SI ZHUANG, HAN LI KANG go global; Club Med Super Med sets sail
2025
Fosun Pharma YP05002 and other small molecules out- licensed overseas